Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
AIBP-LRP2–HDL Signaling Restricts Collateral Growth
2026-08-12
Zhu et al. identify an AIBP-LRP2–HDL–miR-223 pathway that suppresses CXCR4+ stemlike capillary endothelial cell expansion after ischemia. The study proposes that releasing this brake may promote collateral circulation by allowing capillary cells to expand before adopting arterial fates, while also defining experimental controls for evaluating this mechanism.
-
Cholesterol for mRNA-LNP Workflow Optimization
2026-08-12
Use Cholesterol (SKU B1702) as a defined membrane and lipid-nanoparticle variable rather than treating it as a passive excipient. This workflow connects cholesterol-controlled formulation screens with membrane fluidity assays, mRNA-LNP characterization, and localized delivery studies inspired by recent bladder cancer research.
-
EVMPs for Extrahepatic mRNA Delivery
2026-08-11
The reference study presents a bottom-up enveloped virus-mimicking particle (EVMP) that combines a self-assembling peptide with tunable phospholipid envelopes to deliver mRNA beyond the liver. Its optimized formulations targeted lung and spleen tissues, reached substantial lung endothelial and immune-cell populations, and supported IL-12 mRNA therapy in a metastatic lung tumor model.
-
Diethylmaleate as a Redox Assay Design Tool
2026-08-11
Diethylmaleate is more than a glutathione-depleting reagent: it is a controllable redox perturbation for separating antioxidant defense from downstream toxicity. This guide translates insecticide-resistance findings into practical assay-design decisions, controls, and interpretation strategies.
-
Cross-Cell-Line Machine Learning for MoA Prediction
2026-08-10
Warchal and colleagues compared an ensemble tree classifier based on extracted morphological features with a convolutional neural network trained directly on high-content images. The models performed similarly within individual cell lines, but the tree-based approach transferred more effectively to an unseen cell line, highlighting cell-line domain shift as a central challenge in phenotypic mechanism-of-action prediction.
-
From Golgi Imaging to Translational Cancer Insight
2026-08-09
How Golgi-Tracker Green connects live-cell membrane biology with mechanistic oncology research, using Golgi remodeling as a translational readout rather than a purely descriptive imaging endpoint.
-
Acetylcysteine in Redox-Aware Tumor Models
2026-08-08
Acetylcysteine can serve as a controlled redox perturbation in patient-matched 3D tumor-stroma assays. This guide explains how N-acetyl-L-cysteine can sharpen interpretation of pancreatic cancer organoid-fibroblast experiments while avoiding antioxidant-related assay confounding.
-
OM-MSCs, Golgi Stress, and Stroke Recovery
2026-08-07
This study identifies a paracrine mechanism by which olfactory mucosa mesenchymal stem cells (OM-MSCs) reduce Golgi apparatus stress after cerebral ischemia/reperfusion injury. Its data connect PEDF secretion with PI3K/Akt/mTOR pathway activation, reduced oxidative and calcium stress, and suppression of excessive autophagy in cellular and rat models.
-
Norovirus Exploits NINJ1 for Selective NS1 Protein Secretion
2026-08-07
Song et al. reveal that murine norovirus hijacks the host protein NINJ1 to selectively secrete its NS1 protein via a noncanonical pathway, distinct from general DAMP release. This work provides new insight into virus-host interactions and the molecular regulation of programmed cell death–linked protein export.
-
Dual Glutamate Receptor Blockade Counters Soman Neurotoxicit
2026-08-06
The referenced study demonstrates that dual blockade of AMPA and NMDA receptors with IEM-1925 offers superior protection against soman-induced status epilepticus, neurodegeneration, and cognitive impairment in rats. These findings highlight the translational potential of targeted glutamate receptor inhibition for neuroprotection following organophosphorus nerve agent exposure.
-
Disulfiram: Dopamine β-Hydroxylase Inhibitor in Cancer Resea
2026-08-06
Disulfiram’s unique role as a dopamine β-hydroxylase inhibitor and proteasome modulator is transforming experimental strategies in cancer research. From MDA-MB-231 cell-based protocols to troubleshooting cytotoxicity assays, this guide demystifies the practical workflows and highlights the cross-domain innovations catalyzed by this copper-binding compound.
-
Genotyping Kit for Target Alleles: Streamlined DNA Prep & PC
2026-08-05
Accelerate genetic analysis across insects, tissues, fishes, and cells with the Genotyping Kit for target alleles. This all-in-one kit enables rapid, single-tube DNA extraction and robust PCR, minimizing contamination and hands-on time—redefining workflows for molecular biology genotyping research.
-
Rbm25 Regulates ESC Identity via Pluripotency and Epigenetic
2026-08-05
This study uncovers a critical role for Rbm25, traditionally known as an RNA splicing factor, in transcriptional regulation of pluripotency and epigenetic programs in mouse embryonic stem cells (ESCs). The findings establish Rbm25 as a key determinant of ESC fate, revealing mechanisms by which it maintains stem cell identity and modulates transition to totipotent-like states.
-
Decitabine (5-Aza-2'-deoxycytidine): Toxicological Insights
2026-08-04
Explore Decitabine (5-Aza-2'-deoxycytidine) as a DNA methyltransferase inhibitor with nuanced toxicological data and translational relevance, bridging foundational mouse studies and modern cancer epigenetics. This article offers a unique, practical lens for assay design and risk management in oncology research.
-
Firefly Luciferase mRNA: Optimizing Reporter Assays with ARC
2026-08-04
Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) sets a new standard in bioluminescent reporter assays by combining high translation efficiency, low immunogenicity, and robust stability. Discover how its advanced modifications streamline gene expression, cell viability, and in vivo imaging workflows, with practical troubleshooting and protocol optimization tips for reproducible results.